Replies to post #19458 on Positron Corporation (POSC)

[Medtrade77]

Yes F18 will be a major boost for expanding the universe of users. Very exciting indeed. Don’t underestimate this short half life and pharmacologic stress, as they are attributes most practitioners value highly. Digirad insight is SPECT based in nature which they see PET as the threat on the horizon.